Literature DB >> 7504848

Natural history of prostatism: factors associated with discordance between frequency and bother of urinary symptoms.

S J Jacobsen1, C J Girman, H A Guess, L A Panser, C G Chute, J E Oesterling, M M Lieber.   

Abstract

The objective of this study was to assess the association between frequency and bother of urinary symptoms in a population-based cohort of men and to identify psychosocial factors that are related to reporting heightened or subdued bother relative to symptom frequency. The survey was conducted among men aged forty to seventy-nine years in Olmsted County, Minnesota, the baseline component of a prospective cohort study. Men were queried about the frequency of urinary symptom occurrence and the perceived bother associated with the symptoms. A regression analysis of American Urologic Association (AUA) bother scores on AUA frequency scores demonstrated a tight correspondence (r2 = 0.71). Men with bother scores greater than predicted from their frequency scores were more likely to have sought health care for their urinary symptoms than men whose bother was close to predicted (14 versus 5 percent, respectively). These men with heightened bother were older, poorer, more anxious, and had lower general psychologic well-being scores than the men whose bother was similar to that expected from their reported frequency. Men whose bother was lower than would be expected were less likely to have sought health care for urinary symptoms in the past year (3%) but were of similar age and socioeconomic status as compared with men whose bother was close to expected. These men, however, were more depressed than men whose bother was commensurate with reported frequency. While the men who reported greater bother than expected from their symptom frequency were more likely to have sought medical care for urinary symptoms in the past year, it is not clear whether this greater health-care-seeking behavior is because bother captures an additional component of urologic disease or is a manifestation of psychosocial differences.

Entities:  

Mesh:

Year:  1993        PMID: 7504848     DOI: 10.1016/0090-4295(93)90530-n

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  19 in total

1.  Safety and efficacy of the potassium-titanyl-phosphate laser and photoselective vaporization of the prostate for benign prostatic hyperplasia.

Authors:  Claus G Roehrborn
Journal:  Rev Urol       Date:  2006

2.  Underdetection of clinical benign prostatic hyperplasia in a general medical practice.

Authors:  M F Collins; R H Friedman; A Ash; R Hall; M A Moskowitz
Journal:  J Gen Intern Med       Date:  1996-09       Impact factor: 5.128

3.  Effectiveness of medical and surgical therapies for lower urinary tract symptoms in the community setting.

Authors:  Amy E Krambeck; Debra J Jacobson; Michaela E McGree; Deborah J Lightner; Michael M Lieber; Steven J Jacobsen; Jennifer L St Sauver
Journal:  BJU Int       Date:  2012-04-03       Impact factor: 5.588

4.  Associations between variants in the cyclooxygenase 2 enzyme gene (PTGS2) and development of benign prostate enlargement.

Authors:  Jennifer L St Sauver; Michael M Lieber; Susan L Slager; Debra J Jacobson; Michaela E McGree; Steven J Jacobsen
Journal:  BJU Int       Date:  2011-04-11       Impact factor: 5.588

5.  Associations between longitudinal changes in serum estrogen, testosterone, and bioavailable testosterone and changes in benign urologic outcomes.

Authors:  Jennifer L St Sauver; Debra J Jacobson; Michaela E McGree; Cynthia J Girman; George G Klee; Michael M Lieber; Steven J Jacobsen
Journal:  Am J Epidemiol       Date:  2011-03-02       Impact factor: 4.897

6.  Sex Steroid Hormone Levels May Not Explain Gender Differences in Development of Nephrolithiasis.

Authors:  John Joseph Knoedler; Amy E Krambeck; Walter Astorne; Erik Bergstralh; John Lieske
Journal:  J Endourol       Date:  2015-11-05       Impact factor: 2.942

7.  Initial treatment of men with newly diagnosed lower urinary tract dysfunction in the Veterans Health Administration.

Authors:  Bradley A Erickson; Xin Lu; Mary Vaughan-Sarrazin; Karl J Kreder; Benjamin N Breyer; Peter Cram
Journal:  Urology       Date:  2013-11-25       Impact factor: 2.649

8.  A population-based, longitudinal study of erectile dysfunction and future coronary artery disease.

Authors:  Brant A Inman; Jennifer L St Sauver; Debra J Jacobson; Michaela E McGree; Ajay Nehra; Michael M Lieber; Véronique L Roger; Steven J Jacobsen
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

9.  Longitudinal association between prostatitis and development of benign prostatic hyperplasia.

Authors:  Jennifer L St Sauver; Debra J Jacobson; Michaela E McGree; Cynthia J Girman; Michael M Lieber; Steven J Jacobsen
Journal:  Urology       Date:  2008-03       Impact factor: 2.649

10.  Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort.

Authors:  Jennifer L St Sauver; Aruna V Sarma; Debra J Jacobson; Michaela E McGree; Michael M Lieber; Cynthia J Girman; Ajay Nehra; Steven J Jacobsen
Journal:  Am J Epidemiol       Date:  2009-04-24       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.